Provided by Tiger Fintech (Singapore) Pte. Ltd.

Veris Residential

15.03
+0.04000.27%
Post-market: 15.030.00000.00%16:20 EDT
Volume:1.11M
Turnover:16.73M
Market Cap:1.40B
PE:-42.70
High:15.10
Open:15.04
Low:14.88
Close:14.99
Loading ...

Veris Residential downgraded to In Line from Outperform at Evercore ISI

TIPRANKS
·
26 Feb

Veris Residential (VRE) Receives a Buy from Evercore ISI

TIPRANKS
·
26 Feb

Veris Residential Q4 Core Adjusted FFO Decreases, Revenue Increases

MT Newswires Live
·
25 Feb

Veris Residential Inc reports results for the quarter ended December 31 - Earnings Summary

Reuters
·
25 Feb

Veris Residential (VRE) Q4 FFO and Revenues Miss Estimates

Zacks
·
25 Feb

BRIEF-Veris Residential Reports Fourth Quarter, Full Year 2024 Results

Reuters
·
25 Feb

Veris Residential Announces $100 Million Share Buyback

TIPRANKS
·
25 Feb

Veris Residential Q4 FFO $0.11 Misses $0.12 Estimate, Sales $68.08M Beat $67.32M Estimate

Benzinga
·
25 Feb

Veris Residential reports Q4 core AFFO 13c-14c, consensus 12c

TIPRANKS
·
25 Feb

Veris Residential sees 2025 core FFO 61c-63c, consensus 61c

TIPRANKS
·
25 Feb

Veris Residential Inc Outlook FY25 Core Ffo per Share $0.61- $0.63

THOMSON REUTERS
·
25 Feb

Veris Residential Q4 Adjusted Ffo per Share USD 0.11

THOMSON REUTERS
·
25 Feb

Veris Residential Inc FY2025 Ffo Shr View $0.60 -- Lseg Ibes Data

THOMSON REUTERS
·
25 Feb

Press Release: Veris Residential, Inc. Reports Fourth Quarter and Full Year 2024 Results

Dow Jones
·
25 Feb

Acurx Announces Publication of Positive Results from an In-Silico Study Predicting the Microbiome-Restorative Potential of Ibezapolstat in the Treatment of CDI

CNW Group
·
24 Feb

Veris Residential Inc expected to post a loss of 10 cents a share - Earnings Preview

Reuters
·
22 Feb

JPO Grants Acurx Pharmaceuticals Patent in Japan for DNA Polymerase IIIC Inhibitors

PR Newswire
·
19 Feb

Veris Residential Announces Tax Treatment of 2024 Distributions

THOMSON REUTERS
·
18 Feb

Press Release: Veris Residential Announces Tax Treatment of 2024 Distributions

Dow Jones
·
18 Feb

Is it Prudent to Retain Mid-America Stock in Your Portfolio Now?

Zacks
·
14 Feb